Global Markets Direct’s, ‘Nuvo Research Inc. – Product Pipeline Review -2015′, provides an overview of the Nuvo Research Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nuvo Research Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides brief overview of Nuvo Research Inc. including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of Nuvo Research Inc.’s human therapeutic division and enlists all their major and minor projects
• The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest company statement
• Latest news and deals relating to the Nuvo Research Inc.’s pipeline products

Reasons to buy

• Evaluate Nuvo Research Inc.’s strategic position with total access to detailed information on its product pipeline
• Assess the growth potential of Nuvo Research Inc. in its therapy areas of focus
• Identify new drug targets and therapeutic classes in the Nuvo Research Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding the focus areas of Nuvo Research Inc. and exploit collaboration and partnership opportunities
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nuvo Research Inc.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Explore the dormant and discontinued projects of Nuvo Research Inc. and identify potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Nuvo Research Inc. Snapshot 6
Nuvo Research Inc. Overview 6
Key Information 6
Key Facts 6
Nuvo Research Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Nuvo Research Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Combination Treatment Modalities 12
Nuvo Research Inc. - Pipeline Products Glance 13
Nuvo Research Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Nuvo Research Inc. - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combination Treatment Modalities 15
Preclinical Products/Combination Treatment Modalities 16
Nuvo Research Inc. - Drug Profiles 17
(lidocaine hydrochloride + tetracaine hydrochloride) 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Flexicaine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ropivacaine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
triamcinolone acetonide 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
WF-10 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
alprazolam 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
lidocaine hydrochloride 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
ibuprofen 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Mical 1 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Mical 2 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Oxofoam 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
risperidone 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
terbinafine 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
testosterone undecanoate 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
WF-10 liposomal 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Nuvo Research Inc. - Pipeline Analysis 34
Nuvo Research Inc. - Pipeline Products by Target 34
Nuvo Research Inc. - Pipeline Products by Route of Administration 35
Nuvo Research Inc. - Pipeline Products by Molecule Type 36
Nuvo Research Inc. - Pipeline Products by Mechanism of Action 37
Nuvo Research Inc. - Recent Pipeline Updates 38
Nuvo Research Inc. - Dormant Projects 41
Nuvo Research Inc. - Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 43
Disclaimer 44

List of Tables

Nuvo Research Inc., Key Information 6
Nuvo Research Inc., Key Facts 6
Nuvo Research Inc. - Pipeline by Indication, 2015 8
Nuvo Research Inc. - Pipeline by Stage of Development, 2015 10
Nuvo Research Inc. - Monotherapy Products in Pipeline, 2015 11
Nuvo Research Inc. - Combination Treatment Modalities in Pipeline, 2015 12
Nuvo Research Inc. - Phase II, 2015 13
Nuvo Research Inc. - Phase I, 2015 14
Nuvo Research Inc. - IND/CTA Filed, 2015 15
Nuvo Research Inc. - Preclinical, 2015 16
Nuvo Research Inc. - Pipeline by Target, 2015 34
Nuvo Research Inc. - Pipeline by Route of Administration, 2015 35
Nuvo Research Inc. - Pipeline by Molecule Type, 2015 36
Nuvo Research Inc. - Pipeline Products by Mechanism of Action, 2015 37
Nuvo Research Inc. - Recent Pipeline Updates, 2015 38
Nuvo Research Inc. - Dormant Developmental Projects,2015 41
Nuvo Research Inc., Subsidiaries 42

List of Figures

Nuvo Research Inc. - Pipeline by Top 10 Indication, 2015 8
Nuvo Research Inc. - Pipeline by Stage of Development, 2015 10
Nuvo Research Inc. - Monotherapy Products in Pipeline, 2015 11
Nuvo Research Inc. - Combination Treatment Modalities in Pipeline, 2015 12
Nuvo Research Inc. - Pipeline by Top 10 Target, 2015 34
Nuvo Research Inc. - Pipeline by Top 10 Route of Administration, 2015 35
Nuvo Research Inc. - Pipeline by Top 10 Molecule Type, 2015 36
Nuvo Research Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 37